Joshua Morse

Joshua Morse focuses his practice on corporate restructurings and bankruptcy proceedings and represents bondholders, debtors, secured lenders, and indenture trustees.Recent representations include:- Nikola Corporation, and its affiliates, an early-stage growth company that designs and manufactures heavy-duty commercial hydrogen-electric and battery-electric trucks and energy infrastructure solutions, via the HYLA brand, in their chapter 11 cases in the U.S. Bankruptcy Court for the District of Delaware, which resulted in the successful sale of substantially all of their assets and subsequent confirmation of a joint plan of liquidation (In re Nikola Corp., et al.).- Biolase, Inc., and its affiliates, global market leaders in the manufacturing and marketing of dental laser systems, in their chapter 11 cases in the U.S. Bankruptcy Court for the District of Delaware, which resulted in the successful sale of substantially all of their assets to a South Korean company and subsequent confirmation of a joint plan of liquidation (In re Biolase, Inc., et al.).- Sentynl Therapeutics, Inc., in connection with its $46 million acquisition of Eiger Biopharmaceuticals’ Zokinvy® (lonafarnib) program through a chapter 11 sale process where Sentynl served as the “stalking horse bidder” and ultimately prevailed in a competitive auction process (In re Eiger Biopharmaceuticals, Inc.).- Rockley Photonics Holdings Limited, a global leader in photonics-based health monitoring and communications solutions, in its chapter 11 case in the U.S. Bankruptcy Court for the Southern District of New York, successfully confirming a prepackaged chapter 11 plan that allowed Rockley to go private and restructure its business, eliminate more than $120 million of secured debt, and generate approximately $35 million in new funding from existing secured noteholders (In re Rockley Photonics Holdings Limited).- indenture trustee for the 12.5% Senior Secured Notes due 2025 in the Clarus Therapeutics bankruptcy case (In re Clarus Therapeutics Holdings, Inc.).- independent director conducting investigation of claims against affiliates and third parties in Mariner Health Central skilled nursing facility bankruptcy case (In re Mariner Health Central, Inc.).- certain holders of 12% Secured Notes Due 2025 and 4.75% Convertible Notes Due 2026 in connection with the restructuring and recapitalization of Quotient Limited (In re Quotient Limited).Contact: joshua.morse@pillsburylaw.com, M: +1 (415) 309-6833